Monday, July 27, 2026

BTC $65,346 ▲ 0.01%

LIVE

ADA$0.166+0.05%ETH$1,956+0.15%LINK$8.79−0.28%SOL$76.34−0.48%BTC$65,346+0.01%XRP$1.11−0.37%S&P 5007,412+0.05%Nasdaq24,976−0.64%Dow51,947+0.46%RUT2,930−0.35%TNX4.68%−0.51%TYX5.16%−0.17%FVX4.43%−0.78%IRX3.81%+0.13%VIX18.58−0.64%GOLD$4,092.40+0.53%SILVER$59.57+1.12%OIL$84.83−5.02%DXY101.21−0.25%NVDA$206.84−0.92%AAPL$333.02+3.53%TSLA$313.03−2.08%META$595.19−1.80%MSFT$381.70+0.03%AMZN$232.11−0.66%GOOGL$319.74+0.65%Fear & Greed30 — FearADA$0.166+0.05%ETH$1,956+0.15%LINK$8.79−0.28%SOL$76.34−0.48%BTC$65,346+0.01%XRP$1.11−0.37%S&P 5007,412+0.05%Nasdaq24,976−0.64%Dow51,947+0.46%RUT2,930−0.35%TNX4.68%−0.51%TYX5.16%−0.17%FVX4.43%−0.78%IRX3.81%+0.13%VIX18.58−0.64%GOLD$4,092.40+0.53%SILVER$59.57+1.12%OIL$84.83−5.02%DXY101.21−0.25%NVDA$206.84−0.92%AAPL$333.02+3.53%TSLA$313.03−2.08%META$595.19−1.80%MSFT$381.70+0.03%AMZN$232.11−0.66%GOOGL$319.74+0.65%Fear & Greed30 — Fear

Tag

viking holdings

1 article

U.S. Equities69d ago

Regeneron Rises 3.4% on Eye Drug Trial Win; Mobileye Gains on $1.5B Auto Deal

Regeneron's geographic atrophy treatment met primary endpoint in Phase 3 trial while Mobileye landed multi-year European automaker contract